Terms: = Prostate cancer AND PR, PGR, progesterone receptor AND Staging
10 results:
1. Investigation of radiomics models for predicting biochemical recurrence of advanced prostate cancer on pretreatment MR ADC maps based on automatic image segmentation.
Wang H; Wang K; Ma S; Gao G; Wang X
J Appl Clin Med Phys; 2024 Apr; 25(4):e14244. PubMed ID: 38146796
[TBL] [Abstract] [Full Text] [Related]
2. Clinical parameters and nomograms for predicting lymph node metastasis detected with
Onal C; Ozyigit G; Oymak E; Guler OC; Hurmuz P; Tilki B; Reyhan M; Tuncel M; Akyol F
Prostate; 2021 Jul; 81(10):648-656. PubMed ID: 33949694
[TBL] [Abstract] [Full Text] [Related]
3. prostate cancer screening among elderly men in Brazil: should we diagnose or not?
Mori RR; Faria EF; Mauad EC; Rodrigues AA; Dos Reis RB
Int Braz J Urol; 2020; 46(1):34-41. PubMed ID: 31851456
[TBL] [Abstract] [Full Text] [Related]
4. Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast cancer Patients.
Krishna Latha T; Verma A; Thakur GK; Banerjee B; Kaur N; Singh UR; Sharma S
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3321-3329. PubMed ID: 31759355
[TBL] [Abstract] [Full Text] [Related]
5. A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Falk RT; Staff AC; Bradwin G; Karumanchi SA; Troisi R
Cancer Causes Control; 2016 Aug; 27(8):1009-17. PubMed ID: 27357932
[TBL] [Abstract] [Full Text] [Related]
6. Back to the embryonic stage: Nodal as a biomarker for breast cancer progression.
Bar-Eli M
Breast Cancer Res; 2012 May; 14(3):105. PubMed ID: 22643182
[TBL] [Abstract] [Full Text] [Related]
7. [Epidemiologic profile and prognostic factors in clinically localized prostate adenocarcinoma submitted to surgical treatment].
Nassif AE; Tâmbara Filho R; Paula RX; Taguchi WS; Pozzobon HJ
Rev Col Bras Cir; 2009 Aug; 36(4):327-31. PubMed ID: 20076923
[TBL] [Abstract] [Full Text] [Related]
8. [Current treatment in high risk and locally advanced prostate cancer].
Esquena Fernández S; Maroto Rey P; Sancho Pardo G; Palou Redorta J; Villavicencio Mavrich H
Actas Urol Esp; 2007 May; 31(5):445-51. PubMed ID: 17711162
[TBL] [Abstract] [Full Text] [Related]
9. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
Koutsilieris M; Lembessis P; Luu-The V; Sourla A
Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer.
Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W
Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195
[TBL] [Abstract] [Full Text] [Related]
